ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Methodological quality of systematic reviews on treatments for Alzheimer's disease: a cross-sectional study

Zhong, Claire C. W.; Zhao, Jinglun; Wong, Charlene H. L.; Wu, Irene X. Y.*; Mao, Chen; Yeung, Jerry W. F.; Chung, Vincent C. H.南方医科大学; 5
Alzheimers Research & Therapy2022-10-29DOI: 10.1186/s13195-022-01100-w
4被引13阅读
引用收藏
分享

摘要

Background Carefully conducted systematic reviews (SRs) can provide reliable evidence on the effectiveness of treatment strategies for Alzheimer's disease (AD). Nevertheless, the reliability of SR results can be limited by methodological flaws. This cross-sectional study aimed to examine the methodological quality of SRs on AD treatments, along with potentially relevant factors. Methods To identify eligible SRs on AD treatments, four databases including the Cochrane Database of Systematic Reviews, MEDLINE, EMBASE, and PsycINFO were searched. The Assessing the Methodological Quality of Systematic Reviews 2 instrument was used for quality appraisal of SRs. Multivariable regression analyses were used to examine factors related to methodological quality. Results A total of 102 SRs were appraised. Four (3.90%) SRs were considered as high quality; 14 (13.7%), 48 (47.1%), and 36 (35.3%) were as moderate, low, and critically low quality, respectively. The following significant methodological limitations were identified: only 22.5% of SRs registered protocols a priori, 6.9% discussed the rationales of chosen study designs, 21.6% gave a list of excluded studies with reasons, and 23.5% documented funding sources of primary studies. Cochrane SRs (adjusted odds ratio (AOR): 31.9, 95% confidence interval (CI): 3.81-266.9) and SRs of pharmacological treatments (AOR: 3.96, 95%CI: 1.27-12.3) were related to the higher overall methodological quality of SRs. Conclusion Methodological quality of SRs on AD treatments is unsatisfactory, especially among non-Cochrane SRs and SRs of non-pharmacological interventions. Improvement in the following methodological domains requires particular attention due to poor performance: registering and publishing protocols a priori, justifying study design selection, providing a list of excluded studies, and reporting funding sources of primary studies.

学科与关键词

关键词
Alzheimer's diseaseCross-sectional studyMeta-analysisBiasSystematic reviews
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Alzheimers Research & Therapy
发表日期
2022-10-29
卷期
第 14 卷, 第 1 期
页码
159
DOI
10.1186/s13195-022-01100-w
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81973709]; Key Technologies Research and Development Program [2020YFC2008600]; Hunan Nature Science Foundation [2019JJ40348]

作者

  • Z

    Zhong, Claire C. W. (第一作者)

    chinese univ hong kong

  • Z

    Zhao, Jinglun

    chinese univ hong kong

查看全部 7 位作者收起作者
  • W

    Wong, Charlene H. L.

    chinese univ hong kong

  • W

    Wu, Irene X. Y. (通讯)

    5

  • M

    Mao, Chen

    southern med univ

  • Y

    Yeung, Jerry W. F.

    hong kong polytech univ

  • C

    Chung, Vincent C. H.

    chinese univ hong kong

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417